Money Matters
Issue 38
February 2021
As SA continues its lockdown, creating an economy that is under increasing pressure, we at Stone Wealth Management continue to have a positive outlook on our client’s financial futures.
Well here we are in a new year, and it feels as if it’s just a continuation of 2020, with masks, social distancing and illness still all around us – has anything actually changed? In this issue of the Lighthouse, we’ve included some interesting info for you on vaccines and our usual look at the markets, both international and local. While we all need to ‘vasbyt’ for some time still, we are hopeful that 2021 will go from strength to strength.
Reducing your taxable income for TY2021. You need to act now!
The end of the tax year is almost upon us. Are you wanting to still make use of the tax concessions for this year? Qualified contributions to an RA will reduce your taxable income, so if you would like to take up this option, you’ll need to make sure that the funds and application forms are processed and allocated to your retirement fund and tax-free investment, by close of business on the 24th February.
COVID-19 VACCINE SUPPLY
BY JP LANDMAN INDEPENDENT POLITICAL AND ECONOMIC ANALYST.
JP Landman is an independent political and economic analyst and the opinions expressed in this article are his own.
A proverbial storm has developed around South Africa’s procurement, or the perceived lack thereof, of Covid-19 vaccines.
People are understandably anxious. I therefore compiled this note from publicly available information, and trust readers find it useful.
“We help our clients to make sense of the numbers, by converting complicated concepts into jargon-free, plain language.”
LINDA STONIER
RETIREMENT FUNDS:
Exchange control and emigration matters.
The Taxation Laws Amendment Act 2020, and the Tax Administration Laws Amendment Act 2020, were promulgated on 20 January 2020.
How does this affect you?
PERSONALISED MEDICINE:
the next leap forward for health care?
BY JOANNE TUCKA – HEALTH CARE ANALYST, NINETY ONE. DECEMBER 2020
THE FAST VIEW
• Personalised therapies offer better outcomes for patients and a potential revolution in health care.
• We expect immunotherapy and gene therapy to facilitate these therapies.
• Artificial intelligence and new drug development techniques create the potential for both incumbents and new entrants to take market share.
• The COVID-19 pandemic has spurred many of these trends: expediting vaccine research; encouraging remote monitoring of trials; and increasing the use of telemedicine.
• Health care remains highly competitive, with many existing therapeutic areas becoming more crowded.
• We believe innovative companies that have a diverse product mix and participate in new areas of development are better placed to succeed.
• These trends emphasise the importance of taking a global approach to identifying winners and losers.
